Flinterman L E, van Hylckama Vlieg A, Rosendaal F R, Doggen C J M
Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
Circulation. 2008 Sep 23;118(13):1366-72. doi: 10.1161/CIRCULATIONAHA.107.748699. Epub 2008 Sep 8.
Little is known about the consequences of a first venous thrombosis in the upper extremity. We studied the incidence of, survival, and risk factors for recurrence in a follow-up study.
We followed up 224 patients 18 to 70 years of age after a first venous thrombosis of the arm. Information was collected through anticoagulation clinics, the national death registry, discharge letters, and questionnaires. The median follow-up was 3 years, during which time 30 patients experienced a recurrent event, yielding an incidence rate of 43.2 per 1000 person-years. Survival was reduced: 55 of 224 patients died, which was 5.4-fold higher than age- and sex-adjusted population rates (standardized mortality ratio, 5.4; 95% CI, 4.2 to 7.0). The risk of recurrence was 2-fold higher in women than in men (hazard ratio, 1.8; 95% CI, 0.9 to 3.9). A central venous catheter at the time of first thrombosis was associated with a reduced risk of recurrence. A body mass index > or =25 kg/m(2) and a first nonsubclavian thrombosis appeared to increase the risk of a recurrent event. Prothrombotic mutation carriers did not appear to have an increased recurrence risk.
The risk of recurrence was high, with women, patients with body mass index > or =25 kg/m(2), and patients with a first nonsubclavian vein thrombosis having a higher risk of recurrence. Patients with a first venous thrombosis of the arm have a poor vital prognosis.
关于上肢首次静脉血栓形成的后果,人们了解甚少。我们在一项随访研究中对复发率、生存率及风险因素进行了研究。
我们对224例年龄在18至70岁之间的上肢首次静脉血栓形成患者进行了随访。通过抗凝门诊、国家死亡登记处、出院小结及问卷调查收集信息。中位随访时间为3年,在此期间30例患者出现复发事件,复发率为每1000人年43.2例。生存率降低:224例患者中有55例死亡,比年龄和性别校正后的人群死亡率高5.4倍(标准化死亡比,5.4;95%可信区间,4.2至7.0)。女性复发风险比男性高2倍(风险比,1.8;95%可信区间,0.9至3.9)。首次血栓形成时存在中心静脉导管与复发风险降低相关。体重指数≥25kg/m²及首次非锁骨下静脉血栓形成似乎会增加复发事件的风险。血栓形成倾向突变携带者似乎并未有更高的复发风险。
复发风险较高,女性、体重指数≥25kg/m²的患者及首次非锁骨下静脉血栓形成的患者复发风险更高。上肢首次静脉血栓形成的患者生存预后较差。